TITLE

Survival of Dialysis Patients Using Random Survival Forest Model in Low-Dimensional Data with Few-Events

AUTHOR(S)
Rafati, Shideh; Baneshi, Mohammad Reza; Hassani, Laleh; Bahrampour, Abbas
PUB. DATE
November 2019
SOURCE
Journal of Kerman University of Medical Sciences;Nov/Dec2019, Vol. 26 Issue 6, p450
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background:Dialysis is a process for eliminating extra uremic fluids of patients with chronic renal failure. The present study aimed to determine the variables that influence the survival of dialysis patients using random survival forest model (RSFM) in low-dimensional data with low events per variable (EPV). Methods:In this historical cohort study, information was collected from 252 dialysis patients in Bandar Abbas hospitals, Iran. The survival time of the patients was calculated in years from the onset of dialysis to death or until the end of the study in 2016. RSFM was used as the number of events per variable (EPV) was low. The data collected from 252 patients were randomly divided into training and testing sets, and this process was repeated 100 times. C-index and Brier Score (BS) were used to assess the performance of the model in the test set. Results: In this study, 35 (13.9%) mortality cases were observed. Based on the findings, the mean C-index value in training and testing sets was 0.640 and 0.687, and the mean BS value in training and testing sets was 0.017 and 0.023, respectively. The results of the RSFM revealed that BMI, education, occupation, dialysis duration, number of dialysis sessions and age at dialysis onset were the most important factors. Conclusion: RSFM can be used to determine the survival of dialysis patients and manage low-dimensional data with few-events if the researcher desires to select a nonparametric model.
ACCESSION #
141434009

 

Related Articles

  • Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000). Iseki, Kunitoshi; Tozawa, Masahiko; Iseki, Chiho; Takishita, Shuichi; Ogawa, Yoshihide // Kidney International;Feb2002, Vol. 61 Issue 2, p668 

    Demographic trends in the Okinawa Dialysis Study (OKIDS) registry (1971–2000).. Background: The clinical demographics of chronic dialysis patients are changing worldwide. However, long-term data from regional dialysis registries have not yet been analyzed and reported. Methods: The...

  • Survival advantage in Asian American end-stage renal disease patients1. Wong, Joyce S.; Port, Friedrich K.; Hulbert-Shearon, Tempie E.; Carroll, Caitlin E.; Wolfe, Robert A.; Agodoa, Lawrence Y.C.; Daugirdas, John T. // Kidney International;Jun1999, Vol. 55 Issue 6, p2515 

    Survival advantage in Asian American end-stage renal disease patients. Background. An earlier study documented a lower mortality risk for end-stage renal disease (ESRD) patients in Japan compared with the United States. We compared the mortality of Caucasian (white) and Asian American dialysis...

  • Cardiac arrest and sudden death in dialysis units. Karnik, Jwala A.; Young, Belinda S.; Lew, Nancy L.; Herget, Maureen; Dubinsky, Catherine; Lazarus, J. Michael; Chertow, Glenn M. // Kidney International;Jul2001, Vol. 60 Issue 1, p350 

    Cardiac arrest and sudden death in dialysis units. Background. For patients with end-stage renal disease and their providers, dialysis unit-based cardiac arrest is the most feared complication of hemodialysis. However, relatively little is known regarding its frequency or epidemiology, or...

  • Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Mallamaci, Francesca; Zoccali, Carmine; Tripepi, Giovanni; Fermo, Isabella; Benedetto, Francesco A; Cataliotti, Alessandro; Bellanuova, Ignazio; Malatino, Lorenzo Salvatore; Soldarini, Armando // Kidney International;Feb2002, Vol. 61 Issue 2, p609 

    Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients.. Background: We prospectively tested the prediction power of homocysteinemia for all-cause and cardiovascular outcomes in a cohort of 175 hemodialysis patients followed for 29 ± 12 months. Methods: Survival...

  • Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics. Xue, Jay L; Everson, Susan E; Constantini, Edward G; Ebben, James P; Chen, Shu-Cheng; Agodoa, Lawrence Y; Collins, Allan J // Kidney International;Feb2002, Vol. 61 Issue 2, p741 

    Peritoneal and hemodialysis: II. Mortality risk associated with initial patient characteristics.. Background: Patients initiating with peritoneal dialysis (PD) have favorable clinical conditions compared with hemodialysis (HD) patients, which may contribute to the varying results found in...

  • Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease. Osanai, Tomohiro; Nakamura, Masayuki; Sasaki, Satoko; Tomita, Hirofumi; Saitoh, Masayuki; Osawa, Hiroshi; Yamabe, Hideaki; Murakami, Shuichi; Magota, Koji; Okumura, Ken // Kidney International;Dec2003, Vol. 64 Issue 6, p2291 

    Background: Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), is an independent predictor of overall mortality and cardiovascular outcome in hemodialysis patients. However, not only ADMA but also traditional risk factors account for...

  • A baseline study of pediatric dialysis in Texas. Tai, T. W.; Kalia, A. // Pediatric Nephrology;Dec2001, Vol. 16 Issue 12, p1002 

    This study provides a cross-sectional view of the management of 94 Texas children with end-stage renal disease in 1996 and serves as a point of comparison for future changes in management practice. Data collected in 6 pediatric and 18 adult dialysis facilities in Texas revealed that a greater...

  • Grado de dependencia de las personas sometidas a hemodiálisis en Cataluña y evolución de su mortalidad. Andreu-Periz, Lola; Puig-Llobet, Montserrat; Cases-Amenós, Aleix // Nefrologia;2012, Vol. 32 Issue 5, p613 

    Age as well as associated comorbilities of ESRD patients under maintenance haemodialysis, (HD) result in an impairment of their functional autonomy. Our aims were to assess the level of dependence in patients under HD as well as their mortality rate after three years. To do so, we followed the...

  • Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Thomas Gerhardt; Uwe Pöge; Birgit Stoffel-Wagner; Burkhard Klein; Hans-Ulrich Klehr; Tilman Sauerbruch; Rainer P. Woitas // Nephrology Dialysis Transplantation;Jan2008, Vol. 23 Issue 1, p309 

    Background. Beta-trace protein (BTP) has been proposed as an alternative endogenous marker of the glomerular filtration rate. However, possible determinants of BTP in ESRD patients undergoing regular renal replacement therapy have not been evaluated. Methods. Serum levels of BTP,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics